["Allergy, Intolerance": "ACE Inhibitor or ARB Ingredient"]
Performance/Reporting Period
2022
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to represent concepts for medications of angiotensin-converting enzyme (ACE) inhibitor and angiotensin-receptor blocker (ARB) ingredients.
Data Element Scope: This value set may use a model element related to Allergy/Intolerance.
Inclusion Criteria: Includes concepts that represent an allergy or intolerance for prescribable angiotensin-converting enzyme (ACE) inhibitor and angiotensin-receptor blocker (ARB) ingredients only.
Exclusion Criteria: No exclusions.
Data Element Scope: This value set may use a model element related to Allergy/Intolerance.
Inclusion Criteria: Includes concepts that represent an allergy or intolerance for prescribable angiotensin-converting enzyme (ACE) inhibitor and angiotensin-receptor blocker (ARB) ingredients only.
Exclusion Criteria: No exclusions.
Constrained to codes in the Allergy, Intolerance: ACE Inhibitor or ARB Ingredient value set (2.16.840.1.113883.3.526.3.1489)
QDM Datatype and Definition
"Allergy Intolerance"
Data elements that meet criteria using this datatype should document the allergy or intolerance and its corresponding value set.
Timing:
- The prevalence period references the time from the onset date to the abatement date. Often an abatement date is not present as allergy or intolerance is ongoing.
- The author dateTime references the recorded time.
eCQMs using this data element:
QDM Attributes
prevalencePeriod
Prevalance Period is the time from onset dateTime to abatement dateTime.
Last Updated: Jul 08, 2021